Skip to content

Clinical trials

Phase 4 Hepatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 4 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20051
20081
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centers for Disease Control and Prevention2
Gilead Sciences1
National Institute of Allergy and Infectious Diseases (NIAID)1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
National Institute on Drug Abuse (NIDA)1
St. Louis University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis7
Hepatitis C3
Hepatitis B2
Acquired Immunodeficiency Syndrome1
Anemia, Hemolytic1
Fatty Liver1
Fibrosis1
Hemolysis1
Hepatitis A1
Hepatitis B, Chronic1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.